I think Fushi brings up an interesting point. Why would TKT and Aventis sink all of this money into EPO if they didn't have a reasonable expectation of beating AMGN? Did they think AMGN wouldn't mind if TKT tried to take away their best selling drug? My sense is that if TKT looses then they are down for the count. Seems like a big risk to take without an ace in the hole.FS
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. M